• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Personalis, Inc. - Common Stock (NQ: PSNL )

    4.990 +0.330 (+7.08%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Personalis, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    Personalis Announces CEO Retirement and Transition
    From Personalis, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer
    From Personalis, Inc.
    Via Business Wire
    Personalis's Return On Capital Employed Overview
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      Thursday saw 177 companies set new 52-week lows. 
    Via Benzinga
    Expert Ratings for Personalis
    Personalis (NASDAQ:PSNL) has observed the following analyst ratings within the last quarter: 
    Via Benzinga
    Personalis to Present at the 34th Annual Piper Sandler Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis Presents Data from New Platform Features at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
    From Personalis, Inc.
    Via Business Wire
    Personalis Reports Third Quarter 2022 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business
    From Personalis, Inc.
    Via Business Wire
    Personalis to Announce Third Quarter 2022 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer
    From Personalis, Inc.
    Via Business Wire
    Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics
    From Personalis, Inc.
    Via Business Wire
    121 Stocks That Hit Their 52-Week Low
    New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. 
    Via Benzinga
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers
    From Personalis, Inc.
    Via Business Wire
    5 Top Stocks Cathie Wood Bought This Week
    Cathie Wood continues to increase positions in some of her top stocks despite recession fears. She bought names like EXAS and PACB this week. 
    Via InvestorPlace
    Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis: Q2 Earnings Insights
    Personalis (NASDAQ:PSNL) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Personalis beat estimated... 
    Via Benzinga
    Personalis Reports Second Quarter 2022 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics
    From Personalis, Inc.
    Via Business Wire
    Personalis to Announce Second Quarter 2022 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease
    From Personalis, Inc.
    Via Business Wire
    Personalis Reports First Quarter 2022 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis to Present at Upcoming Investor Conferences
    From Personalis, Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Thursday
    During the Thursday's session, 100 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 73 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    During Thursday, 351 stocks hit new 52-week lows. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.